Evidence map›Paper›PMID 34586746›Full record

Trial reportClinical and translational medicine2021

Clinical and molecular features of Epstein-Barr virus-positive diffuse large B-cell lymphoma: Results in a multi-center trial.

Chen Xing Zhao, Jing Jing Wen, Di Fu, Peng Peng Xu, Shu Cheng, Li Wang, Chao Fu Wang, Xiao Chun Fei, Xin Wang, Jian Feng Zhou and 12 more

Abstract readClinical TrialLetterMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Clinical and translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Chen Xing ZhaoFujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China.
Jing Jing WenFujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China.
Di FuState Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Peng Peng XuState Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shu ChengState Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Li WangState Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chao Fu WangState Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xiao Chun FeiState Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xin WangDepartment of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Jian Feng ZhouDepartment of Hematology, Tongji Medical College, Huazhong University of Science and Technology, Tongji Hospital, Wuhan, China.
Li Ping SuDepartment of Hematology, Shanxi Provincial Cancer Hospital, Taiyuan, China.
Zhuo Wen ChenDepartment of Hematology, the First People's Hospital of Foshan, Foshan, China.
Jie Ping ChenDepartment of Hematology, Southwestern Hospital, Third Military Medical University, Chongqing, China.
Mei Yun FangDepartment of Hematology, First Hospital of Dalian Medical University, Dalian, China.
Ting LiuDepartment of Hematology, Hematology Research Laboratory, West China Hospital, Sichuan University, Chengdu, China.
Yong Ping SongDepartment of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Kang YuDepartment of Hematology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yan LiDepartment of Hematology, the First Hospital of China Medical University, Shenyang, China.
Jian GuInstitute of Hematology, Subei People's Hospital of Jiangsu Province, Clinical Medical College of Yangzhou University, Yangzhou, China.
Ming HouDepartment of Hematology, Qilu Hospital, Shandong University, Jinan, China.
Wei Li ZhaoState Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0002-6834-1616
Jian da HuFujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China.ORCID 0000-0002-4438-2544

Funding

Chang Jiang Scholars Program, Shanghai Municipal Education Commission Gaofeng Clinical Medicine 20152206Chang Jiang Scholars Program, Shanghai Municipal Education Commission Gaofeng Clinical Medicine 20152208Clinical Research Plan of Shanghai Hospital Development Center SHDC2020CR1032BJoint Funds for the Innovation of Science and Technology, Fujian province 2016Y9032National Natural Science Foundation of China 81830007National Natural Science Foundation of China 81870315National Natural Science Foundation of China U2005204Program for Innovative Research Team in Science and technology in Fujian Medical University 2017XQ2030
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Epstein-Barr Virus InfectionsLymphoma, Large B-Cell, DiffuseFemaleHerpesvirus 4, HumanHumansMaleMiddle AgedProspective Studies

Identifiers

PMID34586746
PMCPMC8444560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.